Ron Bentsur - Aug 8, 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Aug 8, 2023
Transactions value $
$4,418
Form type
4
Date filed
8/11/2023, 06:07 PM
Previous filing
Jul 24, 2023
Next filing
Aug 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1.78K +120 +0% $14.83 3.23M Aug 8, 2023 Direct F1
transaction NVCT Common Stock Purchase $2.64K +180 +0.01% $14.66 3.23M Aug 11, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 426,759 shares of restricted stock.